Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

resveratrol/põletik

Link salvestatakse lõikelauale
Leht 1 alates 22 tulemused

Boronic acid derivatives of resveratrol for activating deacetylase enzymes

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The disclosed invention is generally in the field of small molecule activators of deacetylase enzymes and the treatment of disorders including cancer, cardiovascular disease, inflammation, obesity, diabetes, and neurodegenerative diseases related to the activation of

Treatment of inflammatory and infectious skin disorders

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION Acne affects up to 85% of adolescents and causes significant morbidity..sup.1 Topical therapy is the first line treatment for mild acne and can be used as adjunctive therapy for moderate to severe acne. However, undesirable side effects such as dryness, redness, and

Compositions comprising a dendrimer-resveratrol complex making and using the same

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

Synergistic anti-inflammatory and antioxidant dietary supplement compositions

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention relates to synergistic compositions for curing or preventing lipoxygenase mediated and free radical mediated disorders in mammals and various forms of degenerative musculoskeletal diseases such as rheumatoid arthritis and osteoarthritis. The present

Synergistic anti-inflammatory and antioxidant dietary supplement compositions

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention relates to synergistic compositions for curing or preventing lipoxygenase mediated and free radical mediated disorders in mammals and various forms of degenerative musculoskeletal diseases such as rheumatoid arthritis and osteoarthritis. The present

Process of obtainment of trans-resveratrol and/or emodin and nutraceutical compositions containing them

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
STATEMENT OF RELATED APPLICATIONS This application is the U.S. National Phase under Chapter II of the Patent Cooperation Treaty (PCT) of PCT International Application No. PCT/BR2008/000028 having an International Filing Date of 30 Jan. 2008, which claims priority on Brazilian Patent Application No.

Pharmaceutical formulations of resveratrol and methods of use thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD The present invention relates generally to pharmaceutical formulations and methods of use thereof, More particularly, the invention relates to pharmaceutical formulations of resveratrol (3,5,4'-trihydroxystilbene) that are useful, for example, in the prevention and treatment of skin

Dietary supplement formulation for controlling inflammation and cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin. BACKGROUND OF THE
FIELD OF THE INVENTION The present invention relates to products having an improved form of resveratrol, to nutraceutical and/or pharmaceutical compositions, particularly the phytotherapic ones, having said products, and to the process for obtaining a complex of resveratrol and cyclodextrin compound
FIELD OF THE INVENTION The present invention is a method for obtaining a formulation of resveratrol and rice bran oil. The resulting product in the form of an oil or solid proves to increase the therapeutic potential of resveratrol by the synergistic action of the components of the rice oil. The

Therapeutic use of resveratrol for hyperglycemia

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the therapeutic use of resveratrol in reducing blood sugar levels for both type 1 and type 2 diabetes mellitus (DM) 2. Description Diabetes can be due to a deficiency of insulin or to a decreased responsiveness to

Nutraceutical compositions and use thereof

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS-REFERENCE TO RELATED APPLICATIONS This application is the National Stage of International Application No. PCT/EP2004/005362, filed May 18, 2004. The present invention relates to novel nutraceutical compositions comprising, as the active ingredients, resveratrol, a derivative, metabolite or

Compositions

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This application is the U.S. national phase of International Application No. PCT/EP2007/006188, filed 12 Jul. 2007, which designated the U.S. and claims priority to European Application No. 06014645.3, filed 14 Jul. 2006, the entire contents of each of which are hereby incorporated by reference. The

Method for the induction of phase 2 related genes in a mammal comprising administering exemestane

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 3, 2017, is named P12589-05_ST25.txt and
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge